UPDATE ARTICLE


Acesso aberto Revisado por pares

5489

Visualizações

Developments and challenges in the diagnosis and treatment of ADHD

Developments and challenges in the diagnosis and treatment of ADHD

Taciana G. Costa Dias1,2,3, Christian Kieling4, Ana Soledade Graeff-Martins1,2,3,5, Tais S. Moriyama1,2,3,5, Luis A. Rohde2,4, Guilherme V. Polanczyk1,2,3,5

Vol.35 Issue Supl.1/2013: S40-S50

ABSTRACT

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder, often associated with other psychiatric comorbidities, functional impairments, and poor long-term outcomes. The objective of this selected review is to describe current advances and challenges in the diagnosis and treatment of ADHD. The disorder is associated with neurobiological underpinnings and is highly heterogeneous in various aspects, such as symptom profiles, cognitive impairments, and neurobiological and genetic features. The efficacy and safety of short-term pharmacological treatments across the life cycle is well studied, but further research investigating long-term treatment, impact of treatment in preschoolers, and non-pharmacological interventions is needed. Future research is also needed to better characterize the neurodevelopmental pathways of the disorder, linking clinical and neurobiological information, less investigated populations, and new interventions.

Keywords: ADHD; heterogeneity; diagnosis; treatment; neurodevelopment


THE CONTENT OF THIS ARTICLE IS NOT AVAILABLE FOR THIS LANGUAGE.


© 2026 All rights reserved